IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation

Area of Science:

• Immunology
• Cell Biology
• Molecular Medicine

Background:

• Eosinophils play a crucial role in diseases such as asthma.
• Targeting IL-5 or its receptor reduces asthma exacerbations.
• IL-3, IL-5, and GM-CSF share a common beta-chain for eosinophil receptors; IL-3 is more potent in promoting protein translation via ERK/p90S6K/RPS6 signaling.

Purpose of the Study:

• To investigate the disease-relevant effects of prolonged eosinophil stimulation with IL-3.

Main Methods:

• Human blood eosinophils were utilized to assess IL-3's impact on IgG-driven degranulation.
• Comparison of IL-3's effects against IL-5 and GM-CSF on eosinophil activation markers (CD32, αMß2 integrin, CD32B/C, CD32A).
• In vitro findings were validated in vivo on airway eosinophils.

Main Results:

• IL-3 exposure, compared to IL-5, further induced eosinophil degranulation on aggregated IgG.
• IL-3 increased the production and activation of CD32 (low-affinity IgG receptor) and αMß2 integrin.
• IL-3 uniquely induced CD32B/C protein expression without altering CD32A protein or CD32B/C mRNA levels.
• In vitro observed changes were recapitulated in vivo on airway eosinophils.

Conclusions:

• This study demonstrates, for the first time, the upregulation of CD32B/C on eosinophils.
• IL-3 is identified as a potent inducer of eosinophil degranulation mediated by CD32 and αMß2 integrin.
• These findings highlight IL-3's significant role in eosinophil activation and potential implications for inflammatory diseases.